"Third phase of clinical trials will last 15 months. There are those who wish to take part in them on a voluntary basis. Results of clinical trials will be presented to the Turkish side. After that, an official statement will be made to the public," the center said.
The protocol was signed between President of Turkish Health Institutes Presidency (TUSEB) Erhan Akdogan and Director of Baku Health Center Asiman Hasanov on March 9, 2022, in connection with the third phase of clinical trials of the Turkovac vaccine in Azerbaijan.
More about: coronavirus vaccine
